Abstract
Rationale
Chronic stress or hypercortisolism may increase the risks of depression, cardiac disorders, and osteoporosis, which are also associated with vitamin D (VD) deficiency. Both glucocorticoid receptor (GR) and vitamin D receptor (VDR) are widely distributed and affect many aspects of human physiology. The cross talk between the two steroids is pervasive, but the effect of glucocorticoids on circulating VD and local VD metabolism remains elusive.
Objectives
To fill this critical gap, we assessed the alterations of circulating VD and VD intracrine system in the brain and myocardium of rats treated with two different doses (0.2 and 2 mg/kg/day, respectively) of dexamethasone (Dex).
Results
Daily treatment with 2 mg/kg of Dex for 10 days induced the rats to a depressive-like state and decreased the expression of both VDR and the cytochromes P450 enzymes involved in VD activation (CYP27B1) and catabolism (CYP24A1) in the prefrontal cortex and hippocampus. Meanwhile, the dose of 0.2 mg/kg Dex increased the expression of VDR in the prefrontal cortex but inhibited CYP27B1/CYP24A1/VDR expression in the hippocampus. Similarly, in the myocardium, the rats treated with Dex showed significantly lower expression of CYP27B1/CYP24A1/VDR. Renal VD metabolism and serum VD status were unchanged in 0.2 mg/kg Dex-treated rats. However, the higher dose suppressed the three key players involved in VD metabolism but did not alter serum VD levels.
Conclusion
These data provide new evidence that glucocorticoids could affect intracrine actions of VD in the brain and myocardium, which suggests the potential involvement of VD in the neural and cardiac dysfunctions induced by glucocorticoid excess.
Similar content being viewed by others
References
Ahmed MA (2013) Impact of vitamin D3 on cardiovascular responses to glucocorticoid excess. J Physiol Biochem 69:267–76
Anacker C, Cattaneo A, Luoni A, Musaelyan K, Zunszain PA, Milanesi E, Rybka J, Berry A, Cirulli F, Thuret S, Price J, Riva MA, Gennarelli M, Pariante CM (2013) Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. Neuropsychopharmacology 38:872–83
Banasr M, Dwyer JM, Duman RS (2011) Cell atrophy and loss in depression: reversal by antidepressant treatment. Curr Opin Cell Biol 23:730–7
Barbany G, Persson H (1992) Regulation of neurotrophin mRNA expression in the rat brain by glucocorticoids. Eur J Neurosci 4:396–403
Barnard K, Colon-Emeric C (2010) Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother 8:4–33
Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29:726–76
Casarotto PC, Andreatini R (2007) Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone. Eur Neuropsychopharmacol 17:735–42
Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319–28
Compston J (2010) Management of glucocorticoid-induced osteoporosis. Nat Rev Rheumatol 6:82–8
Christakos S, Dhawan P, Benn B, Porta A, Hediger M, Oh GT, Jeung EB, Zhong Y, Ajibade D, Dhawan K, Joshi S (2007) Vitamin D: molecular mechanism of action. Ann N Y Acad Sci 1116:340–8
Davidson ZE, Walker KZ, Truby H (2012) Clinical review: do glucocorticosteroids alter vitamin D status? A systematic review with meta-analyses of observational studies. J Clin Endocrinol Metab 97:738–44
Elsayed M, Banasr M, Duric V, Fournier NM, Licznerski P, Duman RS (2012) Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression. Biol Psychiatry 72:258–65
Eyles DW, Burne TH, McGrath JJ (2013) Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol 34:47–64
Feng R, Feng L, Yuan Z, Wang D, Wang F, Tan B, Han S, Li T, Li D, Han Y (2013) Icariin protects against glucocorticoid-induced osteoporosis in vitro and prevents glucocorticoid-induced osteocyte apoptosis in vivo. Cell Biochem Biophys 67(1):189–97. doi:10.1007/s12013-013-9533-8
Furay AR, Bruestle AE, Herman JP (2008) The role of the forebrain glucocorticoid receptor in acute and chronic stress. Endocrinology 149:5482–90
Guidotti G, Calabrese F, Anacker C, Racagni G, Pariante CM, Riva MA (2013) Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment. Neuropsychopharmacology 38:616–27
Harms LR, Burne TH, Eyles DW, McGrath JJ (2011) Vitamin D and the brain. Best Pract Res Clin Endocrinol Metab 25:657–69
Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, Hsieh JC, Jurutka PW (2013) Molecular mechanisms of vitamin D action. Calcif Tissue Int 92:77–98
Jiang P, Zhang WY, Li HD, Cai HL, Liu YP, Chen LY (2013) Stress and vitamin D: Altered vitamin D metabolism in both the hippocampus and myocardium of chronic unpredictable mild stress exposed rats. Psychoneuroendocrinology 38(10):2091–8. doi:10.1016/j.psyneuen.2013.03.017
Jones G, Prosser DE, Kaufmann M (2013) Cytochrome P450-mediated metabolism of vitamin D. J Lipid Res. doi: 10.1194/jlr.R031534
Khan AA, Dragt BS, Porte RJ, Groothuis GM (2010) Regulation of VDR expression in rat and human intestine and liver–consequences for CYP3A expression. Toxicol In Vitro 24:822–9
Kitchener P, Di Blasi F, Borrelli E, Piazza PV (2004) Differences between brain structures in nuclear translocation and DNA binding of the glucocorticoid receptor during stress and the circadian cycle. Eur J Neurosci 19:1837–46
Lavie CJ, Lee JH, Milani RV (2011) Vitamin D and cardiovascular disease will it live up to its hype? J Am Coll Cardiol 58:1547–56
Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A (2006) Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab 17:144–9
Michelson D (2009) Depression: body and brain. Biol Psychiatry 66:405–6
Milaneschi Y, Hoogendijk W, Lips P, Heijboer AC, Schoevers R, van Hemert AM, Beekman AT, Smit JH, Penninx BW (2013) The association between low vitamin D and depressive disorders. Mol Psychiatry. doi: 10.1038/mp.2013.36
Nanri A, Mizoue T, Matsushita Y, Poudel-Tandukar K, Sato M, Ohta M, Mishima N (2009) Association between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis by survey season. Eur J Clin Nutr 63:1444–7
Nemeroff CB, Goldschmidt-Clermont PJ (2012) Heartache and heartbreak—the link between depression and cardiovascular disease. Nat Rev Cardiol 9:526–39
Obradovic D, Gronemeyer H, Lutz B, Rein T (2006) Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem 96:500–9
Pan A, Lu L, Franco OH, Yu Z, Li H, Lin X (2009) Association between depressive symptoms and 25-hydroxyvitamin D in middle-aged and elderly Chinese. J Affect Disord 118:240–3
Pascussi JM, Robert A, Nguyen M, Walrant-Debray O, Garabedian M, Martin P, Pineau T, Saric J, Navarro F, Maurel P, Vilarem MJ (2005) Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest 115:177–86
Rastmanesh R, Beauchet O, Annweiler C (2012) Vitamin D deficiency and depression: causal relationship or artifact? Biofactors 38:317–9
Schuster I (2011) Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta 1814:186–99
Sigwalt AR, Budde H, Helmich I, Glaser V, Ghisoni K, Lanza S, Cadore EL, Lhullier FL, de Bem AF, Hohl A, de Matos FJ, de Oliveira PA, Prediger RD, Guglielmo LG, Latini A (2011) Molecular aspects involved in swimming exercise training reducing anhedonia in a rat model of depression. Neuroscience 192:661–74
Silva-Gomez AB, Aguilar-Salgado Y, Reyes-Hernandez DO, Flores G (2013) Dexamethasone induces different morphological changes in the dorsal and ventral hippocampus of rats. J Chem Neuroanat 47:71–8
Wu-Wong JR, Chen YW, Nakane M, Wolf M (2011) Differential effects of vitamin d receptor agonists on gene expression in neonatal rat cardiomyocytes. Cardiovasc Drugs Ther 25:215–22
Yirmiya R, Bab I (2009) Major depression is a risk factor for low bone mineral density: a meta-analysis. Biol Psychiatry 66:423–32
Zella LA, Meyer MB, Nerenz RD, Lee SM, Martowicz ML, Pike JW (2010) Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol Endocrinol 24:128–47
Zhao G, Ford ES, Li C, Balluz LS (2010) No associations between serum concentrations of 25-hydroxyvitamin D and parathyroid hormone and depression among US adults. Br J Nutr 104:1696–702
Zhou C, Assem M, Tay JC, Watkins PB, Blumberg B, Schuetz EG, Thummel KE (2006) Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 116:1703–12
Acknowledgments
This work was supported by Hunan Provincial Innovation Foundation for Postgraduate (no. CX2013B099).
Conflict of interest
The authors have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jiang, P., Xue, Y., Li, HD. et al. Dysregulation of vitamin D metabolism in the brain and myocardium of rats following prolonged exposure to dexamethasone. Psychopharmacology 231, 3445–3451 (2014). https://doi.org/10.1007/s00213-014-3440-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-014-3440-6